Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo
Pharma
Novo reports strong Q3 for Wegovy pill as potential launches loom
On the back of a solid Q3, and with high hopes for next year, Novo appears to be gradually winning back the confidence of some of its shareholders.
Fraiser Kansteiner
Nov 4, 2026 11:26am
Lilly surges up diabetes reputation rankings to close in on Novo
Oct 28, 2026 3:18am
Lilly fends off Novo’s legal bid to block GLP-1 marketing claims
Oct 27, 2026 10:06am
Inside Teva's Weltruza launch and Novo's GLP-1 strategy
Oct 16, 2026 9:29am
How drugmakers can capitalize on the GLP-1 'consumer overlay'
Oct 7, 2026 10:00am
Novo cites production site corrections amid hemophilia FDA delay
Oct 5, 2026 7:15am
